Literature DB >> 991446

A quantitative test to detect lymphocytes sensitized against the surface of muscle cells.

T A Partridge, P D Smith.   

Abstract

A test is described which assesses quantitatively the capacity of lymphocytes taken from myositic animals to adhere to skeletal muscle cells in vitro. Lymphocytes were taken from guinea-pigs in which a polymyositis had been induced by injection of rabbit skeletal muscle and complete Freund's adjuvant. These lymphocytes attached themselves preferentially to multinucleate myotubes as opposed to the mononuclear cells in tissue cultures made from chick skeletal muscle. The degree of preference was calculated as a Preferential Attachment (PA) index. This index was high in those animals which developed myositis. In contrast lymphocytes from various groups of control guinea-pigs all gave a PA index of around 1. This test is now being adapted for use in the diagnosis and study of polymyositis in human patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991446      PMCID: PMC1541370     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Area and volume measurements by random sampling methods.

Authors:  A S CURTIS
Journal:  Med Biol Illus       Date:  1960-10

2.  The role of myofibrillar fraction of skeletal muscle in the production of experimental polymyositis.

Authors:  D Manghani; T A Partridge; J C Sloper
Journal:  J Neurol Sci       Date:  1974-12       Impact factor: 3.181

3.  Myogenesis in vitro as demonstrated by immunofluorescent staining with antimuscle serum.

Authors:  R L Dawkins; M Lamont
Journal:  Exp Cell Res       Date:  1971-07       Impact factor: 3.905

4.  Experimental myositis in rats. I. Histological and creatine phosphokinase changes, and passive transfer to normal syngeneic rats.

Authors:  M M Esiri; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

5.  Cytotoxic effect of antisera on 51Cr-labelled monolayers of skeletal muscle.

Authors:  R L Dawkins; G Loewi
Journal:  J Pathol       Date:  1973-05       Impact factor: 7.996

6.  Experimental allergic myositis in rats.

Authors:  G Morgan; J B Peter; B B Newbould
Journal:  Arthritis Rheum       Date:  1971 Sep-Oct

7.  Experimental myositis associated with hypersensitivity to muscle.

Authors:  R L Dawkins
Journal:  J Pathol Bacteriol       Date:  1965-10

8.  Experimental myositis: the in-vivo and in-vitro activity of lymph-node cells.

Authors:  S Currie
Journal:  J Pathol       Date:  1971-11       Impact factor: 7.996

9.  In vitro destruction of skeletal muscle by sensitized cells.

Authors:  B A Kakulas
Journal:  Nature       Date:  1966-06-11       Impact factor: 49.962

10.  Tissue-specific cell-surface antigens in embryonic cells.

Authors:  I Goldschneider; A A Moscona
Journal:  J Cell Biol       Date:  1972-05       Impact factor: 10.539

  10 in total
  5 in total

1.  Macrophage migration inhibition studies of lymphocytes taken from guinea-pigs suffering from experimental polymyositis.

Authors:  P D Smith; T A Partridge
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

Review 2.  The muscle cell.

Authors:  J C Sloper; M C Barrett; T A Partridge
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

3.  The uptake of tritium-labelled carnitine by monolayer cultures of human fetal muscle and its potential as a label in cytotoxicity studies.

Authors:  G Cambridge; C M Stern
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

4.  Impaired autologous mixed lymphocyte reaction with normal concanavalin A-induced suppression in adult polymyositis/dermatomyositis.

Authors:  R M Ransohoff; M M Dustoor
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

5.  Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer.

Authors:  S Matsubara; T Shima; M Takamori
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.